bioscience
-
Roper: What’s at stake for businesses with congressional Medicaid decisions?
—
by
The health care debate has so far focused primarily on patient impacts. As well it should, a healthy Colorado is in everyone’s best interests. But there are additional factors Congress should keep in mind as it considers legislation that could reshape Medicaid as we know it – the economic effects. Health care is one-sixth of…
-
Aguilar and Herod: What Colorado can do to support our immigrant communities
—
by
Measures brought before the Colorado General Assembly in this legislative session have shown that the contentious national debate on immigration has been jolting our state’s politics as well. As the federal government has shifted its policies to penalize so-called sanctuary cities and aggressively deport immigrants, we’ve seen conflicting bills introduced here on whether our state…
-
Segrave: Bioscience business good for Colorado economy
—
by
Colorado Bioscience companies are improving patient outcomes, strengthening the health care system and our state’s economy. My company, Silvergate Pharmaceuticals, has developed innovative pediatric treatments designed specifically to fill the unmet needs of children. We are one of the few companies that creates medicines to treat high blood pressure in children. Bioscience is not only…